Back
Amphastar Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
AMPH
Sponsored
The little-known AI stock you need to read about now...
Get the name - FREE.
Buy
55
AMPH
Amphastar Pharmaceuticals
Last Price:
41.12
Seasonality Move:
14.6%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.Amphastar Pharmaceuticals Price Quote
$41.12
+0.01 (+0.71%)
(Updated: April 27, 2024 at 5:53 AM ET)
Amphastar Pharmaceuticals Key Stats
Buy
55
Amphastar Pharmaceuticals (AMPH)
is a Buy
Day range:
$40.50 - $41.42
52-week range:
$35.62 - $67.66
Dividend yield:
0%
P/E ratio:
15.81
P/S ratio:
3.38
P/B ratio:
3.09%
Volume:
263.3K
Avg. volume:
350K
1-year change:
7.73%
Market cap:
$2B
Revenue:
$644.4M
EPS:
$2.58
How Much Does Amphastar Pharmaceuticals Make?
-
How Much Are Amphastar Pharmaceuticals's Sales Annually?
AMPH Revenues are $644.4M -
How Much Profit Does Amphastar Pharmaceuticals's Make A Year?
AMPH net income is $137.5M
Is Amphastar Pharmaceuticals Growing As A Company?
-
What Is Amphastar Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.32% -
What Is Amphastar Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.03%
Amphastar Pharmaceuticals Stock Price Performance
-
Did Amphastar Pharmaceuticals Stock Go Up Last Month?
Amphastar Pharmaceuticals share price went down by -4.86% last month -
Did AMPH's Share Price Rise Over The Last Year?
AMPH share price rose by 7.73% over the past 1 year
What Is Amphastar Pharmaceuticals 52-Week High & Low?
-
What Is Amphastar Pharmaceuticals’s 52-Week High Share Price?
Amphastar Pharmaceuticals has traded as high as $67.66 over the past 52 weeks -
What Is Amphastar Pharmaceuticals’s 52-Week Low Share Price?
Amphastar Pharmaceuticals has traded as low as $35.62 over the past 52 weeks
Amphastar Pharmaceuticals Price To Free Cash Flow
-
Is Amphastar Pharmaceuticals Stock Overvalued?
Amphastar Pharmaceuticals is trading at a price to free cash flow ratio of 14.99 -
Is Amphastar Pharmaceuticals Stock Undervalued?
Amphastar Pharmaceuticals EV to Free Cash Flow ratio is 15.90 -
What Is Amphastar Pharmaceuticals’s Price Earnings Growth Ratio?
AMPH PEG ratio is 0.34 -
Is Amphastar Pharmaceuticals Trading At A Premium To Earnings?
Amphastar Pharmaceuticals EV to EBIT ratio is 11.64
Is It Risky To Buy Amphastar Pharmaceuticals?
-
How Much Debt Does Amphastar Pharmaceuticals Have?
Total long term debt quarterly is $590M -
How Much Cash Does Amphastar Pharmaceuticals Have?
Cash and short term investments quarterly total is $256.8M -
What Is Amphastar Pharmaceuticals’s Book Value Per Share?
Book value per share is 13.30
Is Amphastar Pharmaceuticals Cash Flow Positive?
-
What Is AMPH Cash Flow From Operations?
Cash flow from operations (TTM) is $183.5M -
What Is Amphastar Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $454.1M -
What Is Amphastar Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$649.1M
Amphastar Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
AMPH return on invested capital is 14.38% -
What Is Amphastar Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 11.56% -
What Is AMPH Return On Equity?
ROE is a measure of profitability and is 23.71%
Amphastar Pharmaceuticals Earnings Date & Stock Price
-
What Is Amphastar Pharmaceuticals's Stock Price Today?
A single share of AMPH can be purchased today for 41.11 -
What Is Amphastar Pharmaceuticals’s Stock Symbol?
Amphastar Pharmaceuticals trades on the nasdaq under the ticker symbol: AMPH -
When Is Amphastar Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Amphastar Pharmaceuticals is scheduled on May 9, 2024 -
When Is AMPH's next ex-dividend date?
Amphastar Pharmaceuticals's next ex-dividend date is March 10, 2016 -
How To Buy Amphastar Pharmaceuticals Stock?
You can buy Amphastar Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Amphastar Pharmaceuticals Competitors
-
Who Are Amphastar Pharmaceuticals's Competitors?
Below is a list of companies who compete with Amphastar Pharmaceuticals or are related in some way:
Amphastar Pharmaceuticals Dividend Yield
Data Unavailable
Amphastar Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 3.03% | -3.3% |
Revenue: | 31.91% | 2.76% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 62.60 |
Upside from Last Price: | 52.27% |